Aukera Therapeutics Named 2010 MIT Business Plan Contest Life Sciences Track Winner

Cambridge-based start-up biotech, Aukera Therapeutics, is developing Angiogenin, a novel protein therapy, to treat ALS. As the winner of MIT’s Business Plan Contest, Aukera will receive seed funding and in-kind support from The Cambridge Innovation Center.

Click here to read more.

Share this: